Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Kazuhiro Yanagihara
Kenichi Yoshimura
Miyuki Niimi
Hiroyasu Yasuda
Takahiko Sasaki
Takafumi Nishimura
Hiroshi Ishiguro
Shigemi Matsumoto
Toshiyuki Kitano
Masashi Kanai
Akiko Misawa
Harue Tada
Satoshi Teramukai
Tadashi Mio
Masanori Fukushima
机构：
[1] Kyoto University Hospital,Outpatient Oncology Unit
[2] Kyoto University,Department of Translational Clinical Oncology, Graduate School of Medicine
[3] Kyoto University Hospital,Department of Clinical Trial Design and Management, Translational Research Center
[4] Kyoto University,Department of Multidisciplinary Cancer Treatment, Graduate School of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Non-small cell lung cancer; Phase II study; Docetaxel; S-1; Second-line chemotherapy; Third-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：913 / 918
页数：5
相关论文
共 50 条
  • [21] Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer
    Yasunari Oki
    Takashi Hirose
    Toshimitsu Yamaoka
    Sojiro Kusumoto
    Takao Shirai
    Tomohide Sugiyama
    Kentaro Okuda
    Masanao Nakashima
    Yasunori Murata
    Tohru Ohmori
    Mitsuru Adachi
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 791 - 797
  • [22] Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer
    Oki, Yasunari
    Hirose, Takashi
    Yamaoka, Toshimitsu
    Kusumoto, Sojiro
    Shirai, Takao
    Sugiyama, Tomohide
    Okuda, Kentaro
    Nakashima, Masanao
    Murata, Yasunori
    Ohmori, Tohru
    Adachi, Mitsuru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 791 - 797
  • [23] Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Shimokawa, T.
    Nakamura, Y.
    Iwasawa, S.
    Miyazaki, K.
    Yamanaka, T.
    Takiguchi, Y.
    Okamoto, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2431 - S2431
  • [24] Feasibility study of nivolumab and docetaxel in previously treated patients with advanced non-small cell lung cancer
    Miyazaki, Kazuhito
    Iwasawa, Shunichiro
    Nakamura, Yukiko
    Shimokawa, Tsuneo
    Yamanaka, Takeharu
    Takiguchi, Yuichi
    Okamoto, Hiroaki
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] Phase I/II study of weekly docetaxel in patients with previously treated non-small cell lung cancer (NSCLC).
    Hirata, T
    Kawashita, F
    Ogawa, E
    Masago, K
    Kato, M
    Takada, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 676S - 676S
  • [26] Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancer
    Ozawa, Yuichi
    Inui, Naoki
    Naitoh, Tateaki
    Yasuda, Kazumasa
    Nagayama, Masaharu
    Shirai, Toshihiro
    Suganuma, Hideki
    Fujii, Masato
    Nakamura, Hirotoshi
    Suda, Takafumi
    Chida, Kingo
    LUNG CANCER, 2009, 63 (01) : 68 - 71
  • [27] A phase II study of S-1 for previously treated small cell lung cancer (SCLC)
    Kudo, K.
    Ohyanagi, F.
    Horiike, A.
    Miyauchi, E.
    Motokawa, I.
    Horai, T.
    Mun, M.
    Sakao, Y.
    Okumura, S.
    Nakagawa, K.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Presentation of a Flims study: Randomized phase II study of docetaxel/oxaliplatin and docetaxel in previously treated non-small cell lung cancer patients
    Belvedere, O.
    Follador, A.
    Gaiardo, M.
    Grossi, F.
    Rossetto, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 54 - 54
  • [29] A phase IINCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer
    Molina, Julian R.
    Nikcevich, Daniel
    Hillman, Shauna
    Geyer, Susan
    Drevyanko, Timothy
    Jett, James
    Verdirame, Joseph
    Tazelaar, Henry
    Rowland, Kendrith
    Wos, Edward
    Kutteh, Leila
    Nair, Suresh
    Fitch, Tom
    Flynn, Patrick
    Stella, Philip
    Adjei, Alex A.
    CANCER INVESTIGATION, 2006, 24 (04) : 382 - 389
  • [30] PHASE I/II TRIAL OF S-1 PLUS DOCETAXEL (DTX) FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): KANTO RESPIRATORY DISEASE STUDY GROUP
    Kasai, Takashi
    Mori, Kiyoshi
    Kobayashi, Kunihiko
    Komiyama, Kenichiro
    Minezaki, Syohei
    Uchida, Yuka
    Hoshi, Eishin
    Koyama, Shinichiro
    Eguchi, Keisuke
    Nakayama, Mitsuo
    Kikuchi, Koji
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1211 - S1212
12345